drugset / Trial / NCT00938132

A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers

NCT00938132

Phase 1 Completed 15 enrolled Boryung Pharmaceutical Co., Ltd
Non-randomizedSingle-groupOpen-label

Summary

To evaluate the effect of Fimarsartan on pharmacodynamics, pharmacokinetics, and the safety of warfarin in healthy male volunteers.

Timeline

Start
2009-07
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fimasartan Small molecule
Subject Warfarin Small molecule